Article Text

Download PDFPDF
Antiproliferative and Proapoptotic Effects of Astemizole on Cervical Cancer Cells
  1. María de Guadalupe Chávez-López, MSc*,
  2. Elizabeth Hernández-Gallegos, MSc*,
  3. Alma Y. Vázquez-Sánchez, MSc*,
  4. Patricio Gariglio, PhD and
  5. Javier Camacho, PhD*
  1. *Department of Pharmacology, and
  2. Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del I.P.N., Avenida Instituto Politécnico Nacional 2508, Mexico City, México.
  1. Address correspondence and reprint requests to Javier Camacho, PhD, Department of Pharmacology, Centro de Investigación y Estudios Avanzados del IPN Avenida Instituto Politécnico Nacional 2508, Mexico City 07360, México. E-mail: fcamacho{at}


Objective Cervical cancer is a major cause of mortality among women in developing countries. Thus, it is necessary to offer novel therapies to treat this malignancy. Astemizole has been suggested as a novel and interesting anticancer agent because it targets several proteins involved in cancer including Eag1 (ether à-go-go-1) potassium channels. Eag1 has been proposed as a tumor marker for different types of cancer. Actually, we previously suggested Eag1 channels as cervical cancer and dysplasia markers. Besides, Eag1 has been proposed as a therapeutic target for different malignancies. However, the effect of astemizole in cervical cancer cells is unknown. Therefore, we investigated the effect of astemizole on the proliferation and apoptosis of cervical cancer cells.

Methods Five cervical cancer cell lines (HeLa, SiHa, CaSki, INBL, and C-33A) were cultured according to manufacturer’s instructions. Eag1 protein expression was studied by immunocytochemistry. Cell proliferation was assayed with the MTT method, and apoptosis was investigated by flow cytometry.

Results Eag1 protein expression was observed in different cell lines. Astemizole decreased cell proliferation in up to 40% and increased apoptosis severalfold in all the cell lines studied.

Conclusions Our results suggest astemizole as a potential therapy for cervical cancer.

  • Cervical cancer
  • Astemizole
  • Potassium channels
  • Ether à-go-go
  • Imipramine

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • This work was partially supported by CONACyT grant 141126 to J.C.

  • The authors declare no conflicts of interest.